As a TKI-relevant example, analysis of the degree of tumor shrinkage in response to ALK inhibitors in patients with EML4-ALK positive lung cancer revealed a highly significant positive correlation with overall and progression-free survival [ 26 ].
← all excerpts
Mechanisms of rapid cancer cell reprogramming initiated by targeted receptor tyrosine kinase inhibitors and inherent therapeutic vulnerabilities.
1
—
—